These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34406915)

  • 1. Mortality and Exacerbation Risk by Body Mass Index in Patients with COPD in TIOSPIR and UPLIFT.
    Putcha N; Anzueto AR; Calverley PMA; Celli BR; Tashkin DP; Metzdorf N; Mueller A; Wise RA
    Ann Am Thorac Soc; 2022 Feb; 19(2):204-213. PubMed ID: 34406915
    [No Abstract]   [Full Text] [Related]  

  • 2. TIOtropium Safety and Performance In Respimat
    Zhong N; Moon HS; Lee KH; Mahayiddin AA; Boonsawat W; Isidro MG; Bai C; Mueller A; Metzdorf N; Anzueto A
    Respirology; 2016 Nov; 21(8):1397-1403. PubMed ID: 27490162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of tiotropium in patients switching from HandiHaler to Respimat in the TIOSPIR trial.
    Dahl R; Calverley PM; Anzueto A; Metzdorf N; Fowler A; Mueller A; Wise R; Dusser D
    BMJ Open; 2015 Dec; 5(12):e009015. PubMed ID: 26715479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic Characteristics and Clinical Outcomes in Patients from Latin America Versus the Rest of the World: A TIOSPIR
    Anzueto A; Calverley PMA; Mueller A; Metzdorf N; Haensel M; Jardim JR; Pizzichini E; Giraldo H; Ramirez-Venegas A; Giugno ER
    Arch Bronconeumol (Engl Ed); 2018 Mar; 54(3):140-148. PubMed ID: 29317111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Body mass index and cancer incidence:a prospective cohort study in northern China].
    Guo L; Li N; Wang G; Su K; Li F; Yang L; Ren J; Chang S; Chen S; Wu S; He J; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Mar; 35(3):231-6. PubMed ID: 24831616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Tiotropium Safety and Performance in Respimat® (TIOSPIR®) Trial: Spirometry Outcomes.
    Anzueto A; Wise R; Calverley P; Dusser D; Tang W; Metzdorf N; Dahl R
    Respir Res; 2015 Sep; 16(1):107. PubMed ID: 26369563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial.
    Wise R; Calverley PM; Dahl R; Dusser D; Metzdorf N; Müller A; Fowler A; Anzueto A
    NPJ Prim Care Respir Med; 2015 Nov; 25():15067. PubMed ID: 26540491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of exacerbations as a predictor of subsequent outcomes in patients with COPD.
    Calverley PM; Anzueto AR; Dusser D; Mueller A; Metzdorf N; Wise RA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1297-1308. PubMed ID: 29719385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Low Lean-to-Fat Ratio Reduces the Risk of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients with a Normal or Low Body Mass Index.
    Yang L; Zhu Y; Huang JA; Jin J; Zhang X
    Med Sci Monit; 2019 Jul; 25():5229-5236. PubMed ID: 31302663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR
    Wise RA; Calverley PM; Carter K; Clerisme-Beaty E; Metzdorf N; Anzueto A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():605-616. PubMed ID: 29497289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of an enhanced health-economic model and cost-effectiveness analysis of tiotropium + olodaterol Respimat® fixed-dose combination for chronic obstructive pulmonary disease patients in Italy.
    Selya-Hammer C; Gonzalez-Rojas Guix N; Baldwin M; Ternouth A; Miravitlles M; Rutten-van Mölken M; Goosens LM; Buyukkaramikli N; Acciai V
    Ther Adv Respir Dis; 2016 Oct; 10(5):391-401. PubMed ID: 27405723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of obesity with cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: Insights from TECOS.
    Pagidipati NJ; Zheng Y; Green JB; McGuire DK; Mentz RJ; Shah S; Aschner P; Delibasi T; Rodbard HW; Westerhout CM; Holman RR; Peterson ED;
    Am Heart J; 2020 Jan; 219():47-57. PubMed ID: 31707324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004-2015 cohort studies: no obesity paradox?
    Osadnik T; Nowak D; Osadnik K; Gierlotka M; Windak A; Tomasik T; Mastej M; Łabuz-Roszak B; Jóźwiak K; Lip GYH; Mikhailidis DP; Toth PP; Sattar N; Goławski M; Jóźwiak J; Banach M;
    Cardiovasc Diabetol; 2023 Nov; 22(1):323. PubMed ID: 38017465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of overweight and obesity on acute exacerbations of COPD - subgroup analysis of the Taiwan Obstructive Lung Disease cohort.
    Wei YF; Tsai YH; Wang CC; Kuo PH
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2723-2729. PubMed ID: 28979114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The obesity paradox in patients with peripheral arterial disease.
    Galal W; van Gestel YRBM; Hoeks SE; Sin DD; Winkel TA; Bax JJ; Verhagen H; Awara AMM; Klein J; van Domburg RT; Poldermans D
    Chest; 2008 Nov; 134(5):925-930. PubMed ID: 18641109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased Risk of COPD Exacerbations in Obese Patients.
    Smulders L; van der Aalst A; Neuhaus EDET; Polman S; Franssen FME; van Vliet M; de Kruif MD
    COPD; 2020 Oct; 17(5):485-491. PubMed ID: 32752892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.
    Keating GM
    Drugs; 2012 Jan; 72(2):273-300. PubMed ID: 22217233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship among obesity, nutritional status, and mortality in the critically ill.
    Robinson MK; Mogensen KM; Casey JD; McKane CK; Moromizato T; Rawn JD; Christopher KB
    Crit Care Med; 2015 Jan; 43(1):87-100. PubMed ID: 25289931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease.
    Cheyne L; Irvin-Sellers MJ; White J
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009552. PubMed ID: 26391969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis.
    Cao C; Wang R; Wang J; Bunjhoo H; Xu Y; Xiong W
    PLoS One; 2012; 7(8):e43892. PubMed ID: 22937118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.